Natazia Kit
Product Images NDC 50419-409

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Natazia (NDC 50419-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Strcuture Ev (29132896 F94b 4680 Bff6 Eb95a585c43c 01)

FDA Label Image

Dienogest Chemical Structure (29132896 F94b 4680 Bff6 Eb95a585c43c 02)

FDA Label Image

Figure 1 (29132896 F94b 4680 Bff6 Eb95a585c43c 03)

This is a table showing the median volume of MBL (Menstrual Blood Loss) in mL for a clinical study (308960) that compares the placebo with Natazia® at various points in time (baseline, and cycles 1-7). The median volume for Natazia and Placebo is 20mL and 58mL respectively at baseline.*

FDA Label Image

Figure 2 (29132896 F94b 4680 Bff6 Eb95a585c43c 04)

This text represents a chart displaying the median MBL (menstrual blood loss) volume by cycle for two groups: a placebo and a group taking a medication called Natazia®. The chart shows the median MBL volume in milliliters (mL) for each cycle, with the baseline and the first seven cycles of treatment. The number of participants in each group is also shown.*

FDA Label Image

Birth Control Methods Chart (29132896 F94b 4680 Bff6 Eb95a585c43c 05)

This text describes different methods of birth control and their effectiveness rates. It provides statistics on the number of pregnancies per 100 women according to the chosen method, ranging from less than 1 for top-tier methods like implants and sterilization, to up to 85 for no birth control. It lists a variety of methods, such as birth control pills, condoms, and natural family planning.*

FDA Label Image

Blister Pack (29132896 F94b 4680 Bff6 Eb95a585c43c 06)

This text appears to be the layout of a pill schedule or diagram. It indicates the direction to take pills, and provides details on the position of various color-coded tablets in the schedule. Tablet positions range from 1-28 and are color-coded from dark yellow to white. It provides information on the color and number of tablets for each position in the pill schedule, but does not provide any information on the medication or its purpose.*

FDA Label Image

Trade Carton (29132896 F94b 4680 Bff6 Eb95a585c43c 07)

FDA Label Image

50419 0409 01 Splimage30 A619530a

FDA Label Image

50419 0409 01 Splimage30 A91954ba

FDA Label Image

50419 0409 01 Splimage30 Ac19560a

FDA Label Image

50419 0409 01 Splimage30 Af1957ba

FDA Label Image

50419 0409 01 Splimage30 B219590a

FDA Label Image

Image 01

This appears to be a list of studies and their corresponding findings on the effects of using combined oral contraceptives (COC) versus not using them. The studies are from various locations and time periods, and use different statistical methods to report their findings (e.g. OR, RR, HR). The effects estimates listed in the chart range from -1.5 to 2.0.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.